2-[5-[5-(cyclopropanecarbonylamino)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;2-[5-[5-(methanesulfonamido)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;N-[5-[3-[4-(methylcarbamoyl)-1H-benzimidazol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]morpholine-4-carboxamide;N-methyl-2-[5-[5-[(4-methylpiperazine-1-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide;N-methyl-2-[5-[5-[(1-methylpiperidine-4-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide

C123H114N44O12S — CID 157100205

IUPAC2-[5-[5-(cyclopropanecarbonylamino)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;2-[5-[5-(methanesulfonamido)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;N-[5-[3-[4-(methylcarbamoyl)-1H-benzimidazol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]morpholine-4-carboxamide;N-methyl-2-[5-[5-[(4-methylpiperazine-1-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide;N-methyl-2-[5-[5-[(1-methylpiperidine-4-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide
SMILESCNC(=O)c1cccc2[nH]c(-c3[nH]nc4ncc(-c5cncc(NC(=O)C6CC6)c5)cc34)nc12.CNC(=O)c1cccc2[nH]c(-c3[nH]nc4ncc(-c5cncc(NC(=O)C6CCN(C)CC6)c5)cc34)nc12.CNC(=O)c1cccc2[nH]c(-c3[nH]nc4ncc(-c5cncc(NC(=O)N6CCN(C)CC6)c5)cc34)nc12.CNC(=O)c1cccc2[nH]c(-c3[nH]nc4ncc(-c5cncc(NC(=O)N6CCOCC6)c5)cc34)nc12.CNC(=O)c1cccc2[nH]c(-c3[nH]nc4ncc(-c5cncc(NS(C)(=O)=O)c5)cc34)nc12
InChIInChI=1S/C27H27N9O2.C26H26N10O2.C25H23N9O3.C24H20N8O2.C21H18N8O3S/c1-28-27(38)19-4-3-5-21-22(19)33-25(32-21)23-20-11-17(13-30-24(20)35-34-23)16-10-18(14-29-12-16)31-26(37)15-6-8-36(2)9-7-15;1-27-25(37)18-4-3-5-20-21(18)32-24(31-20)22-19-11-16(13-29-23(19)34-33-22)15-10-17(14-28-12-15)30-26(38)36-8-6-35(2)7-9-36;1-26-24(35)17-3-2-4-19-20(17)31-23(30-19)21-18-10-15(12-28-22(18)33-32-21)14-9-16(13-27-11-14)29-25(36)34-5-7-37-8-6-34;1-25-24(34)16-3-2-4-18-19(16)30-22(29-18)20-17-8-14(10-27-21(17)32-31-20)13-7-15(11-26-9-13)28-23(33)12-5-6-12;1-22-21(30)14-4-3-5-16-17(14)26-20(25-16)18-15-7-12(9-24-19(15)28-27-18)11-6-13(10-23-8-11)29-33(2,31)32/h3-5,10-15H,6-9H2,1-2H3,(H,28,38)(H,31,37)(H,32,33)(H,30,34,35);3-5,10-14H,6-9H2,1-2H3,(H,27,37)(H,30,38)(H,31,32)(H,29,33,34);2-4,9-13H,5-8H2,1H3,(H,26,35)(H,29,36)(H,30,31)(H,28,32,33);2-4,7-12H,5-6H2,1H3,(H,25,34)(H,28,33)(H,29,30)(H,27,31,32);3-10,29H,1-2H3,(H,22,30)(H,25,26)(H,24,27,28)
InChIKeyAFRFVANNKDFZLN-UHFFFAOYSA-N
MW2432.63 g/mol
LogP14.26
Rot. Bonds23

About 2-[5-[5-(cyclopropanecarbonylamino)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;2-[5-[5-(methanesulfonamido)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;N-[5-[3-[4-(methylcarbamoyl)-1H-benzimidazol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]morpholine-4-carboxamide;N-methyl-2-[5-[5-[(4-methylpiperazine-1-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide;N-methyl-2-[5-[5-[(1-methylpiperidine-4-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide

2-[5-[5-(cyclopropanecarbonylamino)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;2-[5-[5-(methanesulfonamido)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;N-[5-[3-[4-(methylcarbamoyl)-1H-benzimidazol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]morpholine-4-carboxamide;N-methyl-2-[5-[5-[(4-methylpiperazine-1-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide;N-methyl-2-[5-[5-[(1-methylpiperidine-4-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide (PubChem CID 157100205) has the molecular formula C123H114N44O12S and a molecular weight of 2432.63 g/mol. Its IUPAC name is 2-[5-[5-(cyclopropanecarbonylamino)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;2-[5-[5-(methanesulfonamido)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;N-[5-[3-[4-(methylcarbamoyl)-1H-benzimidazol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]morpholine-4-carboxamide;N-methyl-2-[5-[5-[(4-methylpiperazine-1-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide;N-methyl-2-[5-[5-[(1-methylpiperidine-4-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide.

Molecular Properties

Compound Name2-[5-[5-(cyclopropanecarbonylamino)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;2-[5-[5-(methanesulfonamido)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;N-[5-[3-[4-(methylcarbamoyl)-1H-benzimidazol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]morpholine-4-carboxamide;N-methyl-2-[5-[5-[(4-methylpiperazine-1-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide;N-methyl-2-[5-[5-[(1-methylpiperidine-4-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide
PubChem CID157100205
Molecular FormulaC123H114N44O12S
Molecular Weight2432.63 g/mol
Exact Mass2430.94
IUPAC Name2-[5-[5-(cyclopropanecarbonylamino)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;2-[5-[5-(methanesulfonamido)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;N-[5-[3-[4-(methylcarbamoyl)-1H-benzimidazol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]morpholine-4-carboxamide;N-methyl-2-[5-[5-[(4-methylpiperazine-1-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide;N-methyl-2-[5-[5-[(1-methylpiperidine-4-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide
SMILESCNC(=O)c1cccc2[nH]c(-c3[nH]nc4ncc(-c5cncc(NC(=O)C6CC6)c5)cc34)nc12.CNC(=O)c1cccc2[nH]c(-c3[nH]nc4ncc(-c5cncc(NC(=O)C6CCN(C)CC6)c5)cc34)nc12.CNC(=O)c1cccc2[nH]c(-c3[nH]nc4ncc(-c5cncc(NC(=O)N6CCN(C)CC6)c5)cc34)nc12.CNC(=O)c1cccc2[nH]c(-c3[nH]nc4ncc(-c5cncc(NC(=O)N6CCOCC6)c5)cc34)nc12.CNC(=O)c1cccc2[nH]c(-c3[nH]nc4ncc(-c5cncc(NS(C)(=O)=O)c5)cc34)nc12
InChIInChI=1S/C27H27N9O2.C26H26N10O2.C25H23N9O3.C24H20N8O2.C21H18N8O3S/c1-28-27(38)19-4-3-5-21-22(19)33-25(32-21)23-20-11-17(13-30-24(20)35-34-23)16-10-18(14-29-12-16)31-26(37)15-6-8-36(2)9-7-15;1-27-25(37)18-4-3-5-20-21(18)32-24(31-20)22-19-11-16(13-29-23(19)34-33-22)15-10-17(14-28-12-15)30-26(38)36-8-6-35(2)7-9-36;1-26-24(35)17-3-2-4-19-20(17)31-23(30-19)21-18-10-15(12-28-22(18)33-32-21)14-9-16(13-27-11-14)29-25(36)34-5-7-37-8-6-34;1-25-24(34)16-3-2-4-18-19(16)30-22(29-18)20-17-8-14(10-27-21(17)32-31-20)13-7-15(11-26-9-13)28-23(33)12-5-6-12;1-22-21(30)14-4-3-5-16-17(14)26-20(25-16)18-15-7-12(9-24-19(15)28-27-18)11-6-13(10-23-8-11)29-33(2,31)32/h3-5,10-15H,6-9H2,1-2H3,(H,28,38)(H,31,37)(H,32,33)(H,30,34,35);3-5,10-14H,6-9H2,1-2H3,(H,27,37)(H,30,38)(H,31,32)(H,29,33,34);2-4,9-13H,5-8H2,1H3,(H,26,35)(H,29,36)(H,30,31)(H,28,32,33);2-4,7-12H,5-6H2,1H3,(H,25,34)(H,28,33)(H,29,30)(H,27,31,32);3-10,29H,1-2H3,(H,22,30)(H,25,26)(H,24,27,28)
InChIKeyAFRFVANNKDFZLN-UHFFFAOYSA-N
XLogP14.26
TPSA745.96 Ų
H-Bond Donors20
H-Bond Acceptors34
Rotatable Bonds23
Heavy Atoms180
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002432.63
LogP ≤ 514.26
H-Bond Donors ≤ 520
H-Bond Acceptors ≤ 1034

Analyze 2-[5-[5-(cyclopropanecarbonylamino)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;2-[5-[5-(methanesulfonamido)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;N-[5-[3-[4-(methylcarbamoyl)-1H-benzimidazol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]morpholine-4-carboxamide;N-methyl-2-[5-[5-[(4-methylpiperazine-1-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide;N-methyl-2-[5-[5-[(1-methylpiperidine-4-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[5-[5-(cyclopropanecarbonylamino)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;2-[5-[5-(methanesulfonamido)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;N-[5-[3-[4-(methylcarbamoyl)-1H-benzimidazol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]morpholine-4-carboxamide;N-methyl-2-[5-[5-[(4-methylpiperazine-1-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide;N-methyl-2-[5-[5-[(1-methylpiperidine-4-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide?
The IUPAC name of 2-[5-[5-(cyclopropanecarbonylamino)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;2-[5-[5-(methanesulfonamido)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;N-[5-[3-[4-(methylcarbamoyl)-1H-benzimidazol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]morpholine-4-carboxamide;N-methyl-2-[5-[5-[(4-methylpiperazine-1-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide;N-methyl-2-[5-[5-[(1-methylpiperidine-4-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide (CID 157100205) is 2-[5-[5-(cyclopropanecarbonylamino)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;2-[5-[5-(methanesulfonamido)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;N-[5-[3-[4-(methylcarbamoyl)-1H-benzimidazol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]morpholine-4-carboxamide;N-methyl-2-[5-[5-[(4-methylpiperazine-1-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide;N-methyl-2-[5-[5-[(1-methylpiperidine-4-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide.
What is the SMILES notation for 2-[5-[5-(cyclopropanecarbonylamino)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;2-[5-[5-(methanesulfonamido)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;N-[5-[3-[4-(methylcarbamoyl)-1H-benzimidazol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]morpholine-4-carboxamide;N-methyl-2-[5-[5-[(4-methylpiperazine-1-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide;N-methyl-2-[5-[5-[(1-methylpiperidine-4-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide?
The canonical SMILES for 2-[5-[5-(cyclopropanecarbonylamino)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;2-[5-[5-(methanesulfonamido)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;N-[5-[3-[4-(methylcarbamoyl)-1H-benzimidazol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]morpholine-4-carboxamide;N-methyl-2-[5-[5-[(4-methylpiperazine-1-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide;N-methyl-2-[5-[5-[(1-methylpiperidine-4-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide is CNC(=O)c1cccc2[nH]c(-c3[nH]nc4ncc(-c5cncc(NC(=O)C6CC6)c5)cc34)nc12.CNC(=O)c1cccc2[nH]c(-c3[nH]nc4ncc(-c5cncc(NC(=O)C6CCN(C)CC6)c5)cc34)nc12.CNC(=O)c1cccc2[nH]c(-c3[nH]nc4ncc(-c5cncc(NC(=O)N6CCN(C)CC6)c5)cc34)nc12.CNC(=O)c1cccc2[nH]c(-c3[nH]nc4ncc(-c5cncc(NC(=O)N6CCOCC6)c5)cc34)nc12.CNC(=O)c1cccc2[nH]c(-c3[nH]nc4ncc(-c5cncc(NS(C)(=O)=O)c5)cc34)nc12.
What is the InChIKey of 2-[5-[5-(cyclopropanecarbonylamino)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;2-[5-[5-(methanesulfonamido)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;N-[5-[3-[4-(methylcarbamoyl)-1H-benzimidazol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]morpholine-4-carboxamide;N-methyl-2-[5-[5-[(4-methylpiperazine-1-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide;N-methyl-2-[5-[5-[(1-methylpiperidine-4-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide?
The InChIKey is AFRFVANNKDFZLN-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H27N9O2.C26H26N10O2.C25H23N9O3.C24H20N8O2.C21H18N8O3S/c1-28-27(38)19-4-3-5-21-22(19)33-25(32-21)23-20-11-17(13-30-24(20)35-34-23)16-10-18(14-29-12-16)31-26(37)15-6-8-36(2)9-7-15;1-27-25(37)18-4-3-5-20-21(18)32-24(31-20)22-19-11-16(13-29-23(19)34-33-22)15-10-17(14-28-12-15)30-26(38)36-8-6-35(2)7-9-36;1-26-24(35)17-3-2-4-19-20(17)31-23(30-19)21-18-10-15(12-28-22(18)33-32-21)14-9-16(13-27-11-14)29-25(36)34-5-7-37-8-6-34;1-25-24(34)16-3-2-4-18-19(16)30-22(29-18)20-17-8-14(10-27-21(17)32-31-20)13-7-15(11-26-9-13)28-23(33)12-5-6-12;1-22-21(30)14-4-3-5-16-17(14)26-20(25-16)18-15-7-12(9-24-19(15)28-27-18)11-6-13(10-23-8-11)29-33(2,31)32/h3-5,10-15H,6-9H2,1-2H3,(H,28,38)(H,31,37)(H,32,33)(H,30,34,35);3-5,10-14H,6-9H2,1-2H3,(H,27,37)(H,30,38)(H,31,32)(H,29,33,34);2-4,9-13H,5-8H2,1H3,(H,26,35)(H,29,36)(H,30,31)(H,28,32,33);2-4,7-12H,5-6H2,1H3,(H,25,34)(H,28,33)(H,29,30)(H,27,31,32);3-10,29H,1-2H3,(H,22,30)(H,25,26)(H,24,27,28).
What are the key properties of 2-[5-[5-(cyclopropanecarbonylamino)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;2-[5-[5-(methanesulfonamido)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;N-[5-[3-[4-(methylcarbamoyl)-1H-benzimidazol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]morpholine-4-carboxamide;N-methyl-2-[5-[5-[(4-methylpiperazine-1-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide;N-methyl-2-[5-[5-[(1-methylpiperidine-4-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide?
2-[5-[5-(cyclopropanecarbonylamino)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;2-[5-[5-(methanesulfonamido)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;N-[5-[3-[4-(methylcarbamoyl)-1H-benzimidazol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]morpholine-4-carboxamide;N-methyl-2-[5-[5-[(4-methylpiperazine-1-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide;N-methyl-2-[5-[5-[(1-methylpiperidine-4-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide has a molecular weight of 2432.63 g/mol, XLogP of 14.26, 23 rotatable bonds, 20 hydrogen bond donors, and 34 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[5-[5-(cyclopropanecarbonylamino)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;2-[5-[5-(methanesulfonamido)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-N-methyl-1H-benzimidazole-4-carboxamide;N-[5-[3-[4-(methylcarbamoyl)-1H-benzimidazol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]morpholine-4-carboxamide;N-methyl-2-[5-[5-[(4-methylpiperazine-1-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide;N-methyl-2-[5-[5-[(1-methylpiperidine-4-carbonyl)amino]-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide is sourced from PubChem (CID 157100205), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).